EU revokes drug export ban from Ranbaxy’s Toansa plant

The European health regulator- the European Medicines Agency (EMA)– revoked the suspension imposed on export of drugs manufactured at the Ranbaxy’s Toansa plant to the European Union (EU), saying medicines manufactured at the site posed no threat to public health despite having a number of manufacturing deficiencies.

Advertisement

Categories: Business & Economy Current Affairs 2017Science and Technology Current Affairs - 2017

Tags:

advertisement

Comments